Thomas Melby

1.6k total citations
20 papers, 1.3k citations indexed

About

Thomas Melby is a scholar working on Infectious Diseases, Virology and Oncology. According to data from OpenAlex, Thomas Melby has authored 20 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Virology and 4 papers in Oncology. Recurrent topics in Thomas Melby's work include HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (8 papers) and Bone health and osteoporosis research (4 papers). Thomas Melby is often cited by papers focused on HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (8 papers) and Bone health and osteoporosis research (4 papers). Thomas Melby collaborates with scholars based in United States, Japan and Italy. Thomas Melby's co-authors include Charles N. Ciampaglio, Gina Briscoe, Harold Erickson, Michael Greenberg, Lars Viktrup, Karl‐Erik Andersson, Mario Maggi, Claus G. Roehrborn, Jean‐Jacques Wyndaele and Tom F. Lue and has published in prestigious journals such as The Journal of Cell Biology, Biochemistry and Journal of Virology.

In The Last Decade

Thomas Melby

20 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Melby United States	19	518	398	383	179	141	20	1.3k
S Gartner United States	16	253 0.5×	619 1.6×	384 1.0×	6 0.0×	9 0.1×	29	1.4k
Brynmor A. Watkins United States	15	286 0.6×	467 1.2×	232 0.6×	4 0.0×	146 1.0×	35	1.3k
Burkhard Manfras Germany	23	284 0.5×	38 0.1×	144 0.4×	36 0.2×	13 0.1×	46	1.5k
M. H. van Oers Netherlands	13	704 1.4×	56 0.1×	69 0.2×	7 0.0×	5 0.0×	29	1.5k
Amelia Escolano United States	15	340 0.7×	158 0.4×	112 0.3×	6 0.0×	8 0.1×	23	959
Munekazu NAKAICHI Japan	18	181 0.3×	16 0.0×	70 0.2×	6 0.0×	13 0.1×	101	1.0k
Monique W. Bruinsma United States	8	459 0.9×	25 0.1×	69 0.2×	14 0.1×	8 0.1×	9	934
Qingsheng Li United States	16	527 1.0×	191 0.5×	92 0.2×	3 0.0×	4 0.0×	29	2.7k
Yasuhiro Nagai Japan	18	329 0.6×	116 0.3×	92 0.2×		30 0.2×	45	986

Countries citing papers authored by Thomas Melby

Since Specialization

Citations

This map shows the geographic impact of Thomas Melby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Melby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Melby more than expected).

Fields of papers citing papers by Thomas Melby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Melby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Melby. The network helps show where Thomas Melby may publish in the future.

Co-authorship network of co-authors of Thomas Melby

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Melby. A scholar is included among the top collaborators of Thomas Melby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Melby. Thomas Melby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lipton, Richard B., Louise Lombard, Dustin Ruff, et al.. (2020). Trajectory of migraine-related disability following long-term treatment with lasmiditan: results of the GLADIATOR study. The Journal of Headache and Pain. 21(1). 20–20. 30 indexed citations

Kay, Jonathan, Masayoshi Harigai, Christina Dickson, et al.. (2020). Changes in selected haematological parameters associated with JAK1/JAK2 inhibition observed in patients with rheumatoid arthritis treated with baricitinib. RMD Open. 6(3). e001370–e001370. 30 indexed citations

Langdahl, Bente, Stuart L. Silverman, Saeko Fujiwara, et al.. (2018). Real-world effectiveness of teriparatide on fracture reduction in patients with osteoporosis and comorbidities or risk factors for fractures: Integrated analysis of 4 prospective observational studies. Bone. 116. 58–66. 69 indexed citations

Silverman, Stuart, Bente Langdahl, Saeko Fujiwara, et al.. (2018). Reduction of Hip and Other Fractures in Patients Receiving Teriparatide in Real-World Clinical Practice: Integrated Analysis of Four Prospective Observational Studies. Calcified Tissue International. 104(2). 193–200. 19 indexed citations

Dempster, David W., Hua Zhou, Robert R. Recker, et al.. (2017). Remodeling- and Modeling-Based Bone Formation With Teriparatide Versus Denosumab: A Longitudinal Analysis From Baseline to 3 Months in the AVA Study. Journal of Bone and Mineral Research. 33(2). 298–306. 53 indexed citations

Dempster, David W., Hua Zhou, Valerie A. Ruff, et al.. (2017). Longitudinal Effects of Teriparatide or Zoledronic Acid on Bone Modeling- and Remodeling-Based Formation in the SHOTZ Study. Journal of Bone and Mineral Research. 33(4). 627–633. 37 indexed citations

Oelke, Matthias, et al.. (2014). Treatment satisfaction with tadalafil or tamsulosin vs placebo in men with lower urinary tract symptoms ( LUTS ) suggestive of benign prostatic hyperplasia ( BPH ): results from a randomised, placebo‐controlled study. British Journal of Urology. 114(4). 568–575. 25 indexed citations

Muram, David, et al.. (2012). Skin reactions in a phase 3 study of a testosterone topical solution applied to the axilla in hypogonadal men. Current Medical Research and Opinion. 28(5). 761–766. 6 indexed citations

Andersson, Karl‐Erik, William C. de Groat, Kevin T. McVary, et al.. (2011). Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: Pathophysiology and mechanism(s) of action. Neurourology and Urodynamics. 30(3). 292–301. 177 indexed citations

10.

Wilson, Karen L., Lei Jin, Sherry Stanfield-Oakley, et al.. (2008). Impact of the Enfuvirtide Resistance Mutation N43D and the Associated Baseline Polymorphism E137K on Peptide Sensitivity and Six-Helix Bundle Structure. Biochemistry. 47(25). 6662–6670. 27 indexed citations

11.

Melby, Thomas, et al.. (2007). Evolution of Genotypic and Phenotypic Resistance during Chronic Treatment with the Fusion Inhibitor T-1249. AIDS Research and Human Retroviruses. 23(11). 1366–1373. 25 indexed citations

12.

Melby, Thomas, Ralph DeMasi, Gabrielle Heilek, et al.. (2007). Association between specific enfuvirtide resistance mutations and CD4 cell response during enfuvirtide-based therapy. AIDS. 21(18). 2537–2539. 20 indexed citations

13.

Melby, Thomas, Prakash Sista, Ralph DeMasi, et al.. (2006). Characterization of Envelope Glycoprotein gp41 Genotype and Phenotypic Susceptibility to Enfuvirtide at Baseline and on Treatment in the Phase III Clinical Trials TORO-1 and TORO-2. AIDS Research and Human Retroviruses. 22(5). 375–385. 57 indexed citations

14.

Mosier, Sarah, Lei Jin, Thomas Melby, et al.. (2005). Impact of Human Immunodeficiency Virus Type 1 gp41 Amino Acid Substitutions Selected during Enfuvirtide Treatment on gp41 Binding and Antiviral Potency of Enfuvirtide In Vitro. Journal of Virology. 79(19). 12447–12454. 107 indexed citations

15.

Eron, Joseph J., Roy M. Gulick, John Bartlett, et al.. (2004). Short‐Term Safety and Antiretroviral Activity of T‐1249, a Second‐Generation Fusion Inhibitor of HIV. The Journal of Infectious Diseases. 189(6). 1075–1083. 103 indexed citations

16.

Lanier, E. Randall, Mounir Ait‐Khaled, Christopher Stone, et al.. (2004). Antiviral Efficacy of Abacavir in Antiretroviral Therapy-Experienced Adults Harbouring HIV-1 with Specific Patterns of Resistance to Nucleoside Reverse Transcriptase Inhibitors. Antiviral Therapy. 9(1). 37–45. 43 indexed citations

17.

Coull, Jason J., et al.. (2001). A Pilot Study of the Use of Mycophenolate Mofetil as a Component of Therapy for Multidrug-Resistant HIV-1 Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 26(5). 423–434. 45 indexed citations

18.

Coull, Jason J., Diana Turner, Thomas Melby, et al.. (2001). A Pilot Study of the Use of Mycophenolate Mofetil as a Component of Therapy for Multidrug-Resistant HIV-1 Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 26(5). 423–434. 24 indexed citations

19.

Melby, Thomas, Charles N. Ciampaglio, Gina Briscoe, & Harold Erickson. (1998). The Symmetrical Structure of Structural Maintenance of Chromosomes (SMC) and MukB Proteins: Long, Antiparallel Coiled Coils, Folded at a Flexible Hinge. The Journal of Cell Biology. 142(6). 1595–1604. 328 indexed citations

20.

Fehon, Richard G., et al.. (1997). Isolation of Mutations in the Drosophila Homologues of the Human Neurofibromatosis 2 and Yeast CDC42 Genes Using a Simple and Efficient Reverse-Genetic Method. Genetics. 146(1). 245–252. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact